Feature | SCAI | May 21, 2020

SCAI Announces 2020 Late-breaking Clinical Studies

SCAI Announces 2020 Late-breaking Clinical Studies, featured clinical research sessions. #SCAI2020

May 21, 2020 — Here is the list of late-breaking study presentations and links to articles about each of them from the Society for Cardiovascular Angiography and Interventions (SCAI) 2020 Scientific Sessions Virtual Conference, which toiok place May 14-16. Sessions share the latest advances in interventional cardiology and featured late-breaking clinical research. Find the entire virtual meeting program and links to the archived on-demand sessions at www.scai.org/scai2020.

Featured Interventional Cardiology Clinical Research
Thursday, May 14, 2020 2:50-4:40 pm EDT

   • A Telemedicine-Based STEMI Network that Encompasses 100 Million Patients – Latin America Telemedicine Infarct Network (LATIN) and Public Good, presented by Sameer Mehta, M.D.

  • Safety and Efficacy of the Synergy Biodegradable-Polymer Everolimus-Eluting Stent vs. Durable-Polymer Drug-Eluting Stents in High-Risk Patients Undergoing PCI: Insights From the TWILIGHT Trial, presented by Usman Baber, M.D

   • Reduction of Revascularization in Patients with Hypertriglyceridemia With Icosapent Ethyl: Insights From REDUCE-IT REVASC, presented by Benjamin E. Peterson, M.D.

   • Autologous CD34 Cell Therapy for Treatment of Coronary Microvascular Dysfunction in Patients With Angina and Non-Obstructive Coronary Arteries, presented by Timothy D. Henry, M.D.

   • Outcomes with Intermediate Left Main Disease on Coronary CT Angiography in the ISCHEMIA Trial (ISCHEMIA Intermediate LM Substudy), presented by Sripal Bangalore, M.D.

   • Optical Coherence Tomography (OCT) Measures Predicting Fractional Flow Reserve (FFR): The OMEF Study, presented by Rocco Vergallo, M.D.

   • Strict Versus No Fasting Prior to Cardiac Catheterization: A Prospective Evaluation of Safety and Clinical Outcomes: Can We Safely Have Our Patients Eat With Cardiac Catheterization – Nix or Allow: The CHOW NOW Study, presented by Abhishek Mishra, M.D.
 

Congenital Heart Disease Late-Breaking Science
Friday, May 15, 2020 1:30-2:25 pm EDT

   • Primary Outcomes of the Harmony Transcatheter Pulmonary Valve Pivotal Trial, presented by John P. Cheatham, M.

   • The Melody Transcatheter Pulmonary Valve: 10-Year Outcomes in the Original U.S. Investigational Device Exemption Trial Cohort, presented by Thomas K. Jones, M.D.

   • One-Year Results From the COMPASSION S3 Trial: Treatment of Patients With a Dysfunctional Right Ventricular Outflow Tract (RVOT) Conduit or Previously Implanted Pulmonic Valve With the Sapien 3 Transcatheter Heart Valve, presented by Vasilis C. Babaliaros, M.D.

 

Other SCAI 2020 News:

How Cardiology Dealt With the COVID-19 Surge in New York City — Columbia Medical Center's efforts explained by Ajay Kirtane, M.D.

Cindy Grines Becomes SCAI President

 

 
For more information or to view the full program: www.scai.org/scai2020

 
#SCAI2020


Related Content

News | Cardiovascular Clinical Studies

November 29, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...

Home November 29, 2023
Home
News | Cardiovascular Clinical Studies

November 29, 2023 — Foldax, Inc., a leader in the development of innovative, polymer heart valves, today announced ...

Home November 29, 2023
Home
News | Cardiovascular Clinical Studies

November 28, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces the first patient in the world has been ...

Home November 28, 2023
Home
News | Cardiovascular Clinical Studies

November 27, 2023 — Esperion announced the presentation of results from a pre-specified, exploratory analysis of CLEAR ...

Home November 27, 2023
Home
News | Cardiovascular Clinical Studies

November 22, 2023 — The first clinical trial to challenge the routine implantation of a defibrillator in myocardial ...

Home November 22, 2023
Home
News | Cardiovascular Clinical Studies

November 15, 2023 — Researchers at the University of Leicester have discovered the mechanism by which cholesterol in our ...

Home November 15, 2023
Home
News | Cardiovascular Clinical Studies

November 6, 2023 — Bristol Myers Squibb announced that research across the company’s cardiovascular franchise will be ...

Home November 06, 2023
Home
News | Cardiovascular Clinical Studies

October 20, 2023 — JenaValve Technology, Inc., developer and manufacturer of the Trilogy Transcatheter Heart Valve (THV) ...

Home October 20, 2023
Home
News | Cardiovascular Clinical Studies

October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home October 12, 2023
Home
Subscribe Now